Abstract
Discerning the interaction of any drug and its receptors is difficult . Before a direct attack on a molecular system that mediates a drug’s action is possible, indirect approaches are important . One of the most fruitful is to corre-late the varying pharmacological potencies of different analogues with varying activities on a test system. As a model of drug-receptor interactions, psychedelic agents present some tempting possibilities as well as almost insuperable difficulties. For instance, d-Lysergicacid diethylamide (d-LSD) is so extra-ordinarily potent, producing effects in man at doses as little as 20 micrograms per 70kg, that one can readily postulate a high degree of affinity for its receptor. Also, there are fairly extensive series of psychedelic drugs which, although apparently differing in structure, produce closely similar effects and seem to be acting on the same receptorsite which raises the question of just what psychotropic effects should be labeled“psychedelic”.
Supported by NIH Grants 1-Ro1-NB-07275 and 1-P01-GM-16492. The author is a recipient of. NIMH Research Career Development Award K3-MH-33128.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Snyder, S. H., Faillace, L., and Hollister, L., Science, 158, 669, (1967).
Snyder, S. H., Faillace, L. A., and Weingartner, H., Amer. J. Psychiat., 125, 357, (1968).
Snyder, S. H., Faillace, L. A., and Weingartner, H., Arch. Gen. Psychiat., 21 , 95, (1969).
Snyder, S. H., Weingartner, H., and Faillace, L. A., in Psychotanimetic Drugs, (ed. by D. H. Efron) , Raven Press, New York, (1969, in press).
Smythies, J. R. and Levy, C. K., J. Mental Sci., 106, 531, (1960).
Freedman, D. X., Appel, J. B., Hartman, F. R., and Molliver, M. E., J. Tharmacol. Exp. Therap., 143, 309, (1964).
Smythies, J. R., et al., Nature , 216, 128, (1967).
Appel, J. B. and Freedman, D. X., Life Sci., 4, 2181, (1967).
Uyeno, E. T., Otis, L. S., and Mitoma, C., Comm. Behav. Biol., A1 , 83, (1968).
Shulgin, A. T., Sargent, T., and Naranjo, C., Nature , 221 , 537, (1969).
Uyeno, E. T., J. Pharmacol. Exp. Therap., 159, 216, (1968).
Ellison, T., Gutziat, L., and Van Loon, E. J., J. Pharmacol, Exp. Therap. 152, 383, (1966).
Freedman, D. X., Amer. J. Physchiat., 119, 843, (1963).
Diaz, P., Ngai, S. H., and Costa, E., Pharmacologist, 1, 372, (1967).
Aghajanian, G. K., Foote, W. E., and Sheard, M. H., Science, 161 , 707, (1969).
Hillarp, N. A., Fixe, K., and Dahlstrom, A., Pharmacol. Rev., 18, 727, (1966).
Aghajanian, G. K. and Sheard, M. H., Comm. Behav. Bioi., 1 , 37, (1968).
Cerletti, A., p. 117 in Neuropharmacology , (ed. by P. B. Bradley, et al.), Elsevier, Amsterdam, (1959).
Iversen, L. L., The Uptake and Storage of Noradrenaiine in Sympathetic Nerves, Cambridge University Press, New York, (1967).
Glowinski, J. and Baldessarini, R. J., Pharmacol. Rev., 18, 1201, (1966).
Eisenfeld, A. J., Axelrod, J. , and Krakoff, L. , J. Pharmacol. Exp. Therap. 156, 107, (1967).
Eisenfeld, A. J., Landsberg, L. , and Axelrod, J., J. Pharmacol. Exp. Therap. 158, 378, (1967).
Iversen, L. L., British J. Pharmacol., 25, 18, (1965).
Hendley, E. D. and Snyder, S. H., Federation Proc. 28, 674, (1969).
Schweitzer, J. W. and Friedhoff, A. J., Biochem. Pharmacol., 15, 2097, (1966) .
Sargent, T. W., et al., Biochem. Biophys. Res. Commun., 29, 126, (1967).
Karreman, G., Isenberg, I., and Szent-Gyorgyi, A., Science , 130, 1191, (1959).
Fukui, K., Yonezawa, T., and Nagata, C., J. Chem. Phys., 27, 1247, (1957).
Axelrod, J., Brady, R. O., Witkop, B., and Evarts, E. V., Ann. N.Y. Acad. Sci., 66, 435, (1957) .
Streitweiser, A., Molecular Orbital Theory for Organic Chemists , Academic Press, New York, (1961).
Snyder, S. H. and Merril, C. R., Proc. Nat. Acad. Sci., U.S., 54, 258, (1965).
Snyder, S. H. and Merril, C. R., p. 229 in Amine Metabolism in Schizophrenia , (ed. by H. Himwich and Smythies) , Pergamon Press, New York, (1966).
Turner, W. J. and Merles, S., A.M.A. Arch. Neurol. Psychiat., 81 , 121 , (1959).
Szara, S. and Axelrod, J., Experientia , 15, 216, (1959).
Szara, S. and Hearst, E., Ann. N.Y. Acad. Sci., 96, 134, (1962).
Kalir, A. and Szara, S. Med. Chem., 6, 716, (1963).
Rosenberg, D. E., Isbell, H., and Miner, E. J., Psychopharmacologia , 4, 39, (1963).
Snyder, S. H. and Richelson, E., Proc. Nat. Acad. Sci., U.S., 60, 206, (1968).
Snyder, S. H. and Richelson, E., p. 1199 in Psychotomimetic: A Review of Progress, (ed. by D. H. Efron) , Public Health Service, Washington, D.C., (1968).
Snyder, S. H. and Richelson, E., in Psychotomimetic Drugs, (ed. by D. H. Efron) , Raven Press, New York, (1969, in press).
Szara, S., p. 460 in Psychotropic Drugs, (ed. by S. Garattini and V. Ghetti) , Elsevier, Amsterdam, (1957).
Gessner, P. K., Godse, D. D., Krull, A. H., and McMullan, J. M., Life Sci, 7, 267, (1968).
Shulgin, A. T., Experientia 20, 366, (1964) .
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1970 Springer Science+Business Media New York
About this chapter
Cite this chapter
Snyder, S.H. (1970). Psychedelic Drug Activity: Electronic, Steric and Biochemical Correlates. In: Kier, L.B. (eds) Molecular Orbital Studies in Chemical Pharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-87536-6_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-87536-6_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-04972-2
Online ISBN: 978-3-642-87536-6
eBook Packages: Springer Book Archive